NextPlat

Q2 FY2026 EarningsQ2 FY26 results significantly beat consensus estimates across major profitability metrics, driven by a dramatic expansion in healthcare margins. Revenue reached $11.88M vs. $11.00M expected, while gross margin surged to 40% (reported) compared to the 35% consensus, fueled by the Medicare Maximum Fair Price program and high-margin 340B contract growth. Normalized EPS of -$0.05 beat the -$0.21 consensus by $0.16, as aggressive operational cost-cutting and headcount reduction offset professional fee increases.